Effect of mutations at the residues R25, D27, P69, and N70 of B95a-MCP on receptor activities for the measles viruses Nagahata wild-type strain and CAM vaccine strain

International Journal of Molecular Medicine

Volumn 3, Issue 1, 1999, Pages 25-32

  Murakami, Yusuke ^a   Fukui, Aya ^b   Seya, Tsukasa ^c   Ueda, Shigeharu ^c   Nagasawa, Shigeharu ^d  

^a HOKKAIDO UNIVERSITY   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c PROBRAIN   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

B95a cell (a marmoset B cell line); Measles virus receptor; Membrane cofactor protein (MCP, CD46); Mutagenesis

Indexed keywords

AMINO ACID; COMPLEMENT COMPONENT C3B; FIBRINOGEN; LEUKOCYTE ANTIGEN; MEMBRANE COFACTOR PROTEIN; MEMBRANE PROTEIN; VIRUS RECEPTOR; VIRUS VACCINE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CELL LINE; CERCOPITHECUS; CHO CELL; CYTOLOGY; GENE EXPRESSION; GENE VECTOR; GENETICS; GIANT CELL; HAMSTER; MEASLES VIRUS; METABOLISM; MOLECULAR GENETICS; MUTATION; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS; VERO CELL; VIROLOGY;

AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; ANTIGENS, CD; ANTIGENS, CD46; CELL LINE, TRANSFORMED; CERCOPITHECUS AETHIOPS; CHO CELLS; COMPLEMENT C3B; CRICETINAE; FIBRINOGEN; GENE EXPRESSION; GENETIC VECTORS; GIANT CELLS; MEASLES VIRUS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; RECEPTORS, VIRUS; SEQUENCE HOMOLOGY, AMINO ACID; VERO CELLS; VIRAL VACCINES;

EID: 0032615593     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.3.1.25     Document Type: Article

References (36)

1. Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin-Combe C and Gerlier D: Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67: 6025-6032, 1993.
2. Dörig RE, Marcil A, Chopra A and Richardson CD: The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell-75: 295-305, 1993.
3. Seya T, Turner JR and Atkinson JP: Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J Exp Med 163: 837-855, 1986.
4. Liszewski MK, Post TW and Atkinson JP: Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol 9: 431-455, 1991.
5. Seya T, Nomura M, Murakami Y, Begum NA, Matsumoto M and Nagasawa S: CD46 (membrane cofactor protein of complement, measles virus receptor): structural and functional divergence among species (Review). Int J Mol Med 1: 809-816, 1998.
6. Lublin DM, Liszewski MK, Post TW, Arce MA, Le Beau MM, Rebentisch MB, Lemons RS, Seya T and Atkinson JP: Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins. J Exp Med 168: 181-194, 1988.
7. Post TW, Liszewski MK, Adams EM, Tedja I, Miller EA and Atkinson JP: Membrane, cofactor protein of the complement system. Alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype. J Exp Med 174: 93-102, 1991.
8. Wild TF, Malvoisin E and Buckland R: Measles virus: both the haemacslutinin and fusion elycoproteins are required for fusion. J Gen Virol 72: 439-442, 1991.
9. Gerlier D, Varior-Krishnan G and Devaux P: CD46-mediatcd measles virus entry. A first key to host-range specificity. Trends Microbiol 3: 338-345, 1995.
10. Kobune F, Sakata H and Sugiura A: Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J Virol 64: 700-705, 1990.
11. Murakami Y, Seya T, Kurita M and Nagasawa S: Molecular cloning of a complementary DNA for a membrane cofactor protein (MCP, CD46)/measles virus receptor on Vero cells and its functional characterization. Biol Pharm Bull 19: 1541-1545, 1996.
12. Murakami Y, Seya T, Kurita M, Fukui A, Ueda S and Nagasawa S: Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus. Biochem J 330: 1351-1359, 1998.
13. Manchester M, Gairin JE, Patterson JB, Alvarez J, Liszewski MK, Eto DS, Atkinson JP and Oldstone MBA: Measles virus recosznizes its receptor, CD46, via two distinct binding domains within SCR1-2. Virology 233: 174-184, 1997.
14. Buchholz CJ, Koller D, Devaux P, Mumenthaler C, Schneider-Schaulies J, Braun W, Gerlier D and Cattaneo R: Mapping of the primary binding site of measles virus to its receptor CD46. J Biol Chem 272: 22072-22079, 1997.
15. Mumenthaler C, Schneider U, Buchholz CJ, Koller D, Braun W and Cattaneo R: A 3D model for the measles vims receptor CD46 based on homology modeling, Monte Carlo simulations, and hcmagglutinin binding studies. Protein Sci 6: 588-597, 1997.
16. Ueda S, Takahashi M, Kurimura T, Minekawa Y, Suzuki N, Yamanishi K, Baba K, Okuno Y, Sasada, T, Ohishi K, Konobe T, Takaku K, Yamada Y, Tanami Y, Kusano F, Hayakawa Y and Kurose T: Development of extremely attenuated live measles virus vaccine (CAM-EX). Biken J 15: 173-177, 1972.
17. Wong TC, Ayata M, Ueda S and Hirano A: Role of biased hypermutation in evolution of subacute sclerosing panencephalitis virus from progenitor acute measles virus. J Virol 65: 2191-2199, 1991.
18. Ueda S, Takahashi M, Minekawa Y, Ogino T, Suzuki N, Yamanishi K, Baba K, Okuno Y, Konobc T, Sasada T and Takaku K: Studies on further attenuated live measles vaccine. I. Adaptation of measles virus to the chorioallantoic membrane of chick embryo and clinical tests on the strain. Biken J 13: 111-116, 1970.
19. Kurita M, Seya T, Matsumoto M, Hara T, Watanabe M and Ueda S: Suppression of the cytopathic effect induced by measles virus vaccine strains using monoclonal antibodies acainst CD46. Vaccine Res 5: 53-55, 1996.
20. Yanagi Y, Cubitt BA and Oldstone MBA: Measles virus inhibits mitogen-induced T cell proliferation but does not directly perturb the T cell activation process inside the cell. Virolosy 187: 280-289, 1992.
21. Seya T, Hara T, Matsumoto M and Akedo H: Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-reeulatcd during cell differentiation. J Immunol 145: 238-245 1990.
22. Okabe M, Nagira M, Kawai Y, Matzno S, Mimura T and Mayumi T: A human sperm antigen possibly involved in binding and/or fusion with zona-free hamster eggs. Fertil Steril 54: 1121-1126, 1990.
23. Nagasawa S and Stroud RM: Mechanism of action of the C3b inactivator: requirement for a high molecular weight cofactor (C3b-C4b1NA cofactor) and production of a new C3b derivative (C3b'). Immunochemistry 14: 749-756, 1977.
24. Nagasawa S, Ichihara C and Stroud RM: Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator. J Immunol 125: 578-582, 1980.
25. Murakami Y, Imamichi T and Nagasawa S: Characterization of C3a anaphylatoxin receptor on guinea-pig macrophages. Immunology 79: 633-638, 1993.
26. Niwa H, Yamamura K and Miyazaki J: Efficient selection for hiuh-expression transfectants with a novel eukaryotic vector. Gene 108: 193-199, 1991.
27. Sambrook J, Fritsch EF and Maniatis T: Expression of cloned genes in cultured mammalian cells. In: Molecular Cloning: A Laboratory Manual. 2nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor pp 16.0-16.81, 1989.
28. Iwata K, Seya T, Yanagi Y, Pesando JM, Johnson PM, Okabe M, Ueda S, Ariga H and Nagasawa S: Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46. J Biol Chem 270: 15148-15152, 1995.
29. Iwata K, Seya T, Ueda S, Ariga H and Nagasawa S: Modulation of complement regulatory function and measles virus receptor function by the scrine-threonine-rich domains of membrane cofactor protein (CD46). Biochem J 304: 169-175, 1994.
30. Seya T and Nagasawa S: A fluorometric method for determination of C3b inactivator. Clin Chim Acta 119: 189-196, 1982.
31. Kojima A, Iwata K, Seya T, Matsumoto M, Ariga H, Atkinson JP and Nagasawa S: Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis. J Immunol 151: 1519-1527, 1993.
32. Iwata K, Seya T, Ariga H and Nagasawa S: Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein. J Immunol 152:3436-3444, 1994.
33. Seya T, Kurita M, Iwata K, Yanagi Y, Tanaka K, Shida K, Hatanaka M, Matsumoto M, Jun S, Hirano A, Ueda S and Nagasawa S: The CD46 transmembranc domain is required for efficient formation of measles-virus-mediated syncytium. Biochem J 322: 135-144, 1997.
34. Sakata H, Kurita M, Murakami Y, Nagasawa S, Watanabe M, Ueda S, Matsumoto M, Sato T, Kobune F and Seya T: A wild-type Japanese measles virus strain inducing predominant early down-regulation of CD46. Biol Pharm Bull 21: 1121-1127, 1998.
35. Hsu EC, Dörig RE, Sarangi F, Marcil A, Jorio C and Richardson CD: Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define reeions important for measles virus bindiric. J Virol 71: 6144-6154, 1997.
36. Hsu EC, Sarangi F, lorio C, Sidhu MS, Udem SA, Dillehay DL, Xu W, Rota PA, Bellini WJ and Richardson CD: A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J Virol 72: 2905-2916, 1998.